GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

BOM:500660 Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹2,970. The average 1-year stock price forecast is 36.01% higher than the current stock price, while the lowest is ₹2,600 (+19.07%) and the highest is ₹3,500 (+60.29%).

Price Target: ₹2,970 (+36.01%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹2,600	₹2,970	₹2,890	₹3,500
Change	+19.07%	+36.01%	+32.33%	+60.29%

Analyst Ratings

The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	1	1	1	1
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Financial Forecast

Revenue This Year

41.94B

Increased by 9.74%

from 38.22B

Revenue Next Year

46.45B

Increased by 10.76%

from 41.94B

EPS This Year

67.98

Increased by 13.08%

from 60.11

EPS Next Year

77.28

Increased by 13.68%

from 67.98

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	32.78B	32.52B	34.54B	37.49B	38.22B	41.94B
Revenue Growth	12.05%	-0.80%	6.21%	8.56%	1.93%	9.74%
Gross Profit	19.00B	19.48B	20.99B	23.35B	24.71B	26.86B
Gross Margin	57.96%	59.89%	60.76%	62.29%	64.65%	64.05%
Operating Income	6.99B	7.48B	8.39B	11.14B	12.43B	13.76B
Net Income	16.95B	6.11B	5.90B	9.28B	10.36B	11.40B
EPS	-	-	-	-	60.11	67.98
EPS Growth	-	-	-	-	10.25%	13.08%
Forward PE	42.30	35.58	44.16	49.88	34.16	32.12
Dividend / Share	30.00	32.00	32.00	42.00	45.00	29.50
Dividend Growth	-	6.67%	-	31.25%	7.14%	-34.44%
Free Cash Flow	10.10B	1.56B	6.70B	11.62B	7.39B	11.60B
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028
High	42.4B
Avg	41.9B
Low	41.5B

Revenue Growth

Revenue Growth	2027	2028
High	10.9%
Avg	9.7%
Low	8.6%

EPS Forecast

EPS	2027	2028
High	-
Avg	67.98
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	13.1%
Low	-

Data Source: S&P Global Market Intelligence

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Price targets and consensus ratings update every hour to every three days.

Data Sources Report a data error